Sign in
4

Changes in Ownership

Guardant Health, Inc. Filed Acc 0001753159-25-000006

Co-Chief Executive Officer sold 100,000 shares at an average $105.05 ($10,505,474)

  • Co-Chief Executive Officer disposed of 387,946 shares (other)
  • Co-Chief Executive Officer acquired 387,946 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Talasaz AmirAli Co-Chief Executive Officer 2025-12-08 Other disposition −387,946 82,854 I
Talasaz AmirAli Co-Chief Executive Officer 2025-12-08 Other acquisition +193,973 218,223 I
Talasaz AmirAli Co-Chief Executive Officer 2025-12-08 Other acquisition +193,973 218,223 I
Talasaz AmirAli Co-Chief Executive Officer 2025-12-08 Sale −15,000 $104.21 $1,563,125 203,223 I
Talasaz AmirAli Co-Chief Executive Officer 2025-12-08 Sale −30,760 $105.34 $3,240,172 172,463 I
Talasaz AmirAli Co-Chief Executive Officer 2025-12-08 Sale −4,240 $106.00 $449,440 168,223 I
Talasaz AmirAli Co-Chief Executive Officer 2025-12-08 Sale −15,000 $104.21 $1,563,125 203,223 I
Talasaz AmirAli Co-Chief Executive Officer 2025-12-08 Sale −30,760 $105.34 $3,240,172 172,463 I
Talasaz AmirAli Co-Chief Executive Officer 2025-12-08 Sale −4,240 $106.00 $449,440 168,223 I
Open-market sales · 100,000 sh · avg $105.05 · $10,505,474
Loading xslF345X05/wk-form4_1765420401.xml…